Biotechnology
Business deals
Amgen buys $2.7bn in BeiGene to sell cancer drugs in China
US biotech company to own one-fifth of Chinese counterpart in all-cash deal
Pharmaceuticals
South Korea's biotech ambitions overshadowed by scandals
Clinical failures and fraud allegations overshadow industry touted as next frontier
Pharmaceuticals
Biogen and Japanese partner Eisai resurrect Alzheimer's drug
Shares of US company gain 27%, make up ground lost after trial's abandonment
Business deals
Singapore-based VC nears first close of $500m tech fund
Vickers Venture Partners plans to invest in biotechnology and artificial intelligence
Biotechnology
Fujifilm's Komori says health care can double to $10bn business
CEO sees M&A boosting scale while mainstay copier operations slow down
Business trends
3D bioprinters turn out liverlike tissues and 'biochips' in Japan
US, EU and Chinese startups also in race to revolutionize medicine
Markets
Henlius Biotech expects to raise up to $477m from Hong Kong IPO
Cornerstone investors have agreed to invest about $140 million
Economy
Singapore may avoid recession after production beats forecasts
Electronics output stabilized in July after sharp drops in previous months
Huawei crackdown
Huawei retains grip on 2nd place in Q2 smartphone shipments
Industry falls 2.3% worldwide as China and US see biggest declines
